Aerie Pharmaceuticals, Inc.
(NASDAQ : AERI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
MDCOMedicines Company
-1.61%47.7620.3%$139.37m
VRXValeant Pharmaceuticals International, Inc.
-2.11%23.2514.1%$136.81m
AMRNAmarin Corporation Plc Sponsored ADR
-0.24%16.711.8%$106.43m
PRGOPerrigo Co. Plc
0.04%55.986.8%$65.35m
JAZZJazz Pharmaceuticals Plc
-0.03%131.412.3%$62.65m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-0.99%141.016.2%$59.44m
SAGESAGE Therapeutics, Inc.
-0.69%159.798.6%$55.88m
MNKMallinckrodt Plc
10.20%3.3020.9%$44.18m
CTLTCatalent Inc
-1.19%51.332.4%$42.63m
ENDPEndo International Plc
-2.02%3.888.8%$39.68m
UTHRUnited Therapeutics Corporation
1.09%80.6914.3%$30.77m
PTLAPortola Pharmaceuticals, Inc.
0.72%30.686.7%$30.44m
ICPTIntercept Pharmaceuticals, Inc.
1.22%68.9016.9%$29.88m
ICLRICON Plc
0.25%149.924.1%$28.03m
AERIAerie Pharmaceuticals, Inc.
-4.41%22.096.8%$26.55m

Company Profile

Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on June 22, 2005 and is headquartered in Durham, NC.